Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial.

Autor: McBane RD 2nd; Vascular Medicine Division, Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: mcbane.robert@mayo.edu., Loprinzi CL; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Zemla T; Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA., Tafur A; Cardiovascular Division, North Shore University Health System, Evanston, Illinois, USA., Sanfilippo K; Hematology and Medical Oncology, Siteman Cancer Center, Washington University, St. Louis, Missouri, USA., Liu JJ; Hematology and Medical Oncology, Illinois Cancer Care, Peoria, Illinois, USA., Garcia DA; Hematology Division, University of Washington, Seattle, Washington, USA., Heun J; Dean Hematology and Medical Oncology Group, Madison, Wisconsin, USA., Gundabolu K; Hematology and Medical Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Onitilo AA; Hematology and Medical Oncology, Cancer Care & Research Center, Marshfield Clinic, Marshfield, Wisconsin, USA., Perepu U; Hematology and Medical Oncology, University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, USA., Drescher MR; Cardiovascular Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA., Henkin S; Cardiovascular Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA., Houghton D; Vascular Medicine Division, Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota, USA., Ashrani A; Hematology Division, Mayo Clinic, Rochester, Minnesota, USA., Billett H; Montefiore Medical Center, Bronx, New York, USA., McCue SA; Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA., Lee MK; Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA., Le-Rademacher JG; Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA., Wysokinski WE; Vascular Medicine Division, Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota, USA.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Jun; Vol. 22 (6), pp. 1704-1714. Date of Electronic Publication: 2024 Mar 25.

Letter to the Editor: Experience with subcutaneous desmopressin in patients with von Willebrand disease (VWD) and qualitative platelet function disorders.

Autor: Saey S; Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Sharathkumar A; Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.; University of Iowa Stead Family Children's Hospital, Department of Pediatric Hematology and Oncology, Iowa City, Iowa, USA., Watkinson K; University of Iowa Stead Family Children's Hospital, Department of Pediatric Hematology and Oncology, Iowa City, Iowa, USA., Krantz M; University of Iowa Stead Family Children's Hospital, Department of Pediatric Hematology and Oncology, Iowa City, Iowa, USA., Currie A; University of Iowa Stead Family Children's Hospital, Department of Pediatric Hematology and Oncology, Iowa City, Iowa, USA., Perepu U; University of Iowa Stead Family Children's Hospital, Department of Pediatric Hematology and Oncology, Iowa City, Iowa, USA., Shinkle M; University of Iowa Stead Family Children's Hospital, Department of Pediatric Hematology and Oncology, Iowa City, Iowa, USA.; Department of Pharmaceutical Care, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.

Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2023 Mar; Vol. 29 (2), pp. 676-680. Date of Electronic Publication: 2023 Jan 17.

Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration.

Autor: Tritschler T; Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.; Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Mathieu ME; Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada., Skeith L; Department of Medicine, University of Calgary, Calgary, AB, Canada., Rodger M; Department of Medicine, McGill University, Montreal, QC, Canada., Middeldorp S; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Brighton T; Department of Haematology, New South Wales Health Pathology Randwick, Prince of Wales Hospital, Sydney, NSW, Australia., Sandset PM; Department of Haematology, Oslo University Hospital and University of Oslo, Oslo, Norway., Kahn SR; Department of Medicine, McGill University, Montreal, QC, Canada.; Divisions of Internal Medicine and Clinical Epidemiology, Jewish General Hospital/Lady Davis Institute, Montreal, QC, Canada., Angus DC; University of Pittsburgh and UPMC Health System, Pittsburgh, PA, USA., Blondon M; Division of Angiology and Haemostasis, Faculty of Medicine and Geneva University Hospitals, Geneva, Switzerland., Bonten MJ; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands., Cattaneo M; Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy., Cushman M; Departments of Medicine and Pathology & Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, VT, USA., Derde LPG; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.; Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., DeSancho MT; Division of Hematology-Oncology, Department of Medicine, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY, USA., Diehl JL; Service de Médecine Intensive - Réanimation, Hôpital Européen Georges Pompidou, Assistance Publique - Hôpitaux de Paris, Paris, France.; Innovative Therapies in Haemostasis, INSERM UMR-S1140, Paris University, Paris, France., Goligher E; Interdivisional Department of Critical Care, University of Toronto, Toronto, ON, Canada.; Division of Respirology, Department of Medicine, University Health Network, Toronto, ON, Canada., Jilma B; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Jüni P; Applied Health Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada.; Department of Medicine and Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada., Lawler PR; Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada.; Ted Rogers Centre for Heart Research, Toronto, ON, Canada.; Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada., Marietta M; Dipartimento Oncologia ed Ematologia, Azienda Ospedaliero-Universitaria di Modena, Ospedale Policlinico, Modena, Italy., Marshall JC; Department of Critical Care Medicine, St Michael's Hospital, Toronto, ON, Canada., McArthur C; Auckland City Hospital, Intensive Care, Auckland, New Zealand., Miranda CH; Division of Emergency Medicine, Department of Internal Medicine, Ribeirão Preto School of Medicine, São Paulo University, Ribeirão Preto, Brazil., Mirault T; Innovative Therapies in Haemostasis, INSERM UMR-S1140, Paris University, Paris, France.; PARCC, INSERM U970, Paris, France.; Hôpital Européen Georges-Pompidou, Assistance Publique - Hôpitaux de Paris, Paris, France., Morici N; Intensive Cardiac Care Unit and De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Perepu U; Department of Internal Medicine, University of Iowa, Iowa City, IA, USA., Schörgenhofer C; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Sholzberg M; St. Michael's Hospital and Departments of Medicine, and Laboratory Medicine and Pathobiology, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, ON, Canada., Spyropoulos AC; Feinstein Institutes for Medical Research and The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, and Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, New York, NY, USA., Webb SA; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia., Zarychanski R; Department of Internal Medicine, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.; Cancer Care Manitoba, Research Institute of Oncology and Haematology, Winnipeg, MB, Canada., Zuily S; Vascular Medicine Division and Regional Competence Center for Marfan Syndrome, Inserm, DCAC and CHRU-Nancy, Université de Lorraine, Nancy, France., Le Gal G; Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2020 Nov; Vol. 18 (11), pp. 2958-2967. Date of Electronic Publication: 2020 Oct 01.

Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial.

Autor: McBane RD 2nd; Vascular Medicine Division, Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota.; Hematology Division, Mayo Clinic, Rochester, Minnesota.; Cardiovascular Department, Mayo Clinic, Rochester, Minnesota., Wysokinski WE; Vascular Medicine Division, Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota.; Hematology Division, Mayo Clinic, Rochester, Minnesota.; Cardiovascular Department, Mayo Clinic, Rochester, Minnesota., Le-Rademacher JG; Health Science Research Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota., Zemla T; Health Science Research Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota., Ashrani A; Vascular Medicine Division, Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota.; Hematology Division, Mayo Clinic, Rochester, Minnesota., Tafur A; NorthShore Medical Group, Evanston, Illinois., Perepu U; Medical Oncology, University of Iowa, Iowa City, Iowa., Anderson D; Department of Hematology, Oncology and Transplantation, University of Minnesota, Regions Hospital, St Paul, Minnesota., Gundabolu K; Department of Oncology and Hematology, University of Nebraska Medical Center, Omaha, Nebraska., Kuzma C; Department of Hematology and Oncology, First Health of the Carolinas, Pinehurst, North Carolina., Perez Botero J; Froedtert Cancer Center, Milwaukee, Wisconsin., Leon Ferre RA; Medical Oncology Department, Mayo Clinic, Rochester, Minnesota., Henkin S; Department of Cardiology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire., Lenz CJ; Vascular Medicine Division, Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota.; Cardiovascular Department, Mayo Clinic, Rochester, Minnesota., Houghton DE; Vascular Medicine Division, Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota.; Hematology Division, Mayo Clinic, Rochester, Minnesota.; Cardiovascular Department, Mayo Clinic, Rochester, Minnesota., Vishnu P; Department of Oncology and Hematology, Mayo Clinic, Jacksonville, Florida., Loprinzi CL; Medical Oncology Department, Mayo Clinic, Rochester, Minnesota.

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2020 Feb; Vol. 18 (2), pp. 411-421. Date of Electronic Publication: 2019 Nov 28.

Dabigatran-Associated Thrombocytopenia.

Autor: Rafiullah; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA., de Magalhaes-Silverman M, Perepu U

Publikováno v: American journal of therapeutics [Am J Ther] 2018 Nov/Dec; Vol. 25 (6), pp. e701-e704.